BRED participated in the 2024 Lingnan High Quality Research Forum on Male Reproduction!
December 19, 2024
In order to further standardize the human sperm bank and assisted reproductive male technology services, strengthen quality control, improve service quality, and ensure maternal and infant safety, the Guangdong Medical Association has successfully held the 2024 Lingnan Male Reproductive High Quality Research Forum in Guangzhou, Guangdong Province from November 22-24, 2024. The academic conference, with the theme of "Male Reproductive Health and Infertility: Challenges, Innovations, and Frontier Research," invited renowned experts in the fields of human sperm banks and assisted reproductive male health in China to give special lectures, covering topics such as safety assessment and monitoring of human sperm banks and assisted reproductive male health technologies. During the conference, standardized training was held on male infertility diagnosis techniques and quality control of semen analysis in 2024. National level experts in assisted reproductive technology evaluation were invited to give special lectures and standardized training.
BRED participated in the conference and demonstrated the company's sperm hyaluronic acid binding assay (solid-phase capture method),
sperm DNA fragment flow cytometry detection (acridine orange SCSA method), semen reactive oxygen species (ROS) staining solution, three digit sperm morphology analysis mechanical counter, fully automatic semen biochemical immunoassay analyzer, and the operation process of supporting detection projects during the conference, which were recognized by the attending experts. You are welcome to visit the official website
www.spermfunc.com for more information.